logo
Share SHARE
FONT-SIZE Plus   Neg

Walgreen Posts Lower Q2 Profit - Quick Facts

Walgreen Co. (WAG) reported a decline in its second-quarter net earnings to $683 million or $0.78 per share from $739 million or $0.80 per share a year ago. On average, 23 analysts polled by Thomson Reuters expected earnings per share of $0.77 for the quarter. Analysts' estimates typically exclude one-time items.

The company said this year's results benefited from one extra day versus last year because of leap year. Compared with last year, the mild cough/cold and flu season impacted net earnings per share by 3 cents, while the effect of no longer being part of the Express Scripts, Inc. pharmacy provider network as of January 1, 2012, impacted results by 7 cents per share.

Quarterly sales went up 0.8 percent to $18.65 billion from prior-year quarter's $18.50 billion, whereas 20 analysts estimated revenues of $18.52 billion for the quarter. Front-end comparable store sales rose 2.1 percent in the second quarter.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT